BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1656997)

  • 1. Elevation of cyclic AMP levels in HL-60 cells accumulated in G1 or G2 by transmethylation inhibitors.
    Prytz PS; Bang BE; Endresen PC; Møller C; Aarbakke J
    Biochem Pharmacol; 1991 Oct; 42(9):1761-6. PubMed ID: 1656997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and transmethylation metabolites in HL-60 cells.
    Endresen PC; Loennechen T; Kildalsen H; Aarbakke J
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1318-24. PubMed ID: 8819518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells.
    Djurhuus R; Svardal AM; Ueland PM
    Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine increases the relative number of apoptotic cells and reduces the relative number of apoptotic bodies in HL-60 cells treated with 3-deazaadenosine.
    Endresen PC; Prytz PS; Lysne S; Aarbakke J
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1245-53. PubMed ID: 8014868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cell cycle perturbation by transmethylation inhibitors.
    Prytz PS; Aarbakke J
    Biochem Pharmacol; 1990 Jan; 39(1):203-6. PubMed ID: 2297355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts.
    Svendsrud DH; Loennechen T; Winberg JO
    Biochem Pharmacol; 1997 May; 53(10):1511-20. PubMed ID: 9260879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological modifications of apoptosis in HL-60 cells: effects of homocysteine and cytochalasins on apoptosis initiated by 3-deazaadenosine.
    Endresen PC; Fandrem J; Eide TJ; Aarbakke J
    Virchows Arch; 1995; 426(3):257-66. PubMed ID: 7773505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine.
    Sherman ML; Shafman TD; Spriggs DR; Kufe DW
    Cancer Res; 1985 Nov; 45(11 Pt 2):5830-4. PubMed ID: 3863710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Deazaadenosine. S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes.
    Zimmerman TP; Iannone M; Wolberg G
    J Biol Chem; 1984 Jan; 259(2):1122-6. PubMed ID: 6693378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell death initiated by 3-deazaadenosine in HL-60 cells is apoptosis and is partially inhibited by homocysteine.
    Endresen PC; Eide TJ; Aarbakke J
    Biochem Pharmacol; 1993 Dec; 46(11):1893-901. PubMed ID: 8267639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Deazaadenosine-induced disorganization of macrophage microfilaments.
    Stopford CR; Wolberg G; Prus KL; Reynolds-Vaughn R; Zimmerman TP
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4060-4. PubMed ID: 3858863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation.
    Morita Y; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1339-44. PubMed ID: 6168684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 3-deazaadenosine on homocysteine and atherosclerosis in apolipoprotein E-deficient mice.
    Langheinrich AC; Braun-Dullaeus RC; Walker G; Jeide I; Schilling R; Tammoscheit K; Dreyer T; Fink L; Bohle RM; Haberbosch W
    Atherosclerosis; 2003 Dec; 171(2):181-92. PubMed ID: 14644386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells.
    Pepe S; Tortora G; Noguchi PD; Marti GE; Washington GC; Cho-Chung YS
    Cancer Res; 1991 Dec; 51(23 Pt 1):6263-7. PubMed ID: 1657383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells.
    Jurgensen CH; Huber BE; Zimmerman TP; Wolberg G
    J Immunol; 1990 Jan; 144(2):653-61. PubMed ID: 1967270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: evidence for a methylation reaction essential to cytolysis.
    Zimmerman TP; Wolberg G; Duncan GS
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6220-4. PubMed ID: 216017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosylhomocysteine levels are not involved in the spasmolytic activity of 3-deazaadenosine in guinea-pig lung parenchyma.
    Gieske TH; Doherty NS; Raddatz R; Stephens D
    Pharmacology; 1991; 42(3):151-5. PubMed ID: 1647535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
    Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
    Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
    Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against a requirement for phospholipid methylation in adenylate cyclase activation by hormones. Methyltransferase inhibitors do not impair cyclic AMP accumulation induced by glucagon or beta-adrenergic agents in rat hepatocytes.
    Schanche JS; Ogreid D; Døskeland SO; Refsnes M; Sand TE; Ueland PM; Christoffersen T
    FEBS Lett; 1982 Feb; 138(2):167-72. PubMed ID: 6279442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.